Home›Companies›Biotech & Pharma›Invirsa

Invirsa, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 8, 2025·Suggest an edit

About Invirsa

Invirsa is a private company based in Columbus, Ohio. It has reported $9,876,460 raised in four offerings on Form D since December 2020.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 22, 2025Aug 6, 2025amended Aug 8, 2025$2,860,000fully sold14$204KEquity, Debt, Options, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
Nov 14, 2023Nov 29, 2023$999,998fully sold1$999KEquityRule 506(b)Form D ↗
Dec 21, 2022Dec 29, 2022$5,976,217of $7.7M target8$747KEquityRule 506(b)Form D ↗
Nov 12, 2020Dec 11, 2020$40,245fully sold1$40,245EquityRule 506(b)Form D ↗
Total, four offerings$9,876,460

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Invirsa's Form D filed Aug 8, 2025.

RW
Rachael Wingo
Executive officer
WE
Wayne Embree
Director
TW
Tim Willis
Director
RS
Robert Shalwitz
President and director
FV

Earlier filings also listed Samuel Lee (director, last listed Nov 2023), Michael Venerable (director, last listed Dec 2020) and Bethany George (director, last listed Dec 2020).

Sources

  1. SECInvirsa, Inc. Form D, filed Aug 6, 2025
  2. SECInvirsa, Inc. filing history